Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

Net loss of Unichem Laboratories reported to Rs 39.93 crore in the quarter ended September 2025 as against net profit of Rs 43.37 crore during the previous quarter ended September 2024. Sales declined 18.31% to Rs 356.90 crore in the quarter ended September 2025 as against Rs 436.88 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales356.90436.88 -18 OPM %2.1614.76 - PBDT25.4269.76 -64 PBT-4.6943.37 PL NP-39.9343.37 PL Powered by Capital Market - Live News

Net loss of Unichem Laboratories reported to Rs 11.89 crore in the quarter ended September 2025 as against net profit of Rs 24.63 crore during the previous quarter ended September 2024. Sales rose 14.11% to Rs 578.96 crore in the quarter ended September 2025 as against Rs 507.36 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales578.96507.36 14 OPM %11.4310.94 - PBDT78.9159.39 33 PBT47.4427.13 75 NP-11.8924.63 PL Powered by Capital Market - Live News

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Unichem Laboratories announced that USFDA has classified the inspection of the company`s Roha API facility as Voluntary Action Initiated (VAI) and received the Establishment Inspection Report. Powered by Capital Market - Live News